Multiple Shots on Goal in Biotech #shorts
Multiple Shots on Goal in Biotech #shorts Biotech is often described as a “binary bet”—one product, one chance, and if the trial data doesn’t hold, it all collapses. But Serina Therapeutics is rewriting that narrative. With a platform spanning multiple therapeutic areas, they are building not just one pipeline, but…